294 related articles for article (PubMed ID: 34040906)
1. Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016.
Thomas A; Karakattu S; Cagle J; Hoskere G
Cureus; 2021 Apr; 13(4):e14605. PubMed ID: 34040906
[TBL] [Abstract][Full Text] [Related]
2. Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database.
Klikovits T; Hoda MA; Dong Y; Arns M; Baumgartner B; Errhalt P; Geltner C; Machan B; Pohl W; Hutter J; Eckmayr J; Studnicka M; Flicker M; Cerkl P; Kirchbacher K; Klepetko W
Wien Klin Wochenschr; 2016 Sep; 128(17-18):627-34. PubMed ID: 27457873
[TBL] [Abstract][Full Text] [Related]
3. Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years.
Lin RT; Chang YY; Wang JD; Lee LJ
J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):463-470. PubMed ID: 30072200
[TBL] [Abstract][Full Text] [Related]
4. Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study.
van Kooten JP; Belderbos RA; von der Thüsen JH; Aarts MJ; Verhoef C; Burgers JA; Baas P; Aalbers AGJ; Maat APWM; Aerts JGJV; Cornelissen R; Madsen EVE
Thorax; 2022 Dec; 77(12):1260-1267. PubMed ID: 35149582
[TBL] [Abstract][Full Text] [Related]
5. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.
Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W
Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956
[TBL] [Abstract][Full Text] [Related]
6. Clustering of malignant pleural mesothelioma in asbestos factories: a subgroup analysis in a 29-year follow-up study to identify high-risk industries in Taiwan.
Lee LJ; Lin CK; Pan CH; Cheng Y; Chang YY; Liou SH; Wang JD
BMJ Open; 2018 Dec; 8(12):e021063. PubMed ID: 30530573
[TBL] [Abstract][Full Text] [Related]
7. Treatment patterns and outcomes in older patients with advanced malignant pleural mesothelioma: Analyses of Surveillance, Epidemiology, and End Results-Medicare data.
Danese MD; Daumont M; Nwokeji E; Gleeson M; Penrod JR; Lubeck D
Cancer Rep (Hoboken); 2022 Sep; 5(9):e1568. PubMed ID: 34698447
[TBL] [Abstract][Full Text] [Related]
8. A Rare Case of Malignant Pleural Mesothelioma in a Young Healthy Male Without Asbestos Exposure.
Khatib S; Asad O; Asad H; Sabobeh T
Cureus; 2021 Aug; 13(8):e17199. PubMed ID: 34540427
[TBL] [Abstract][Full Text] [Related]
9. Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972-2009.
Soeberg MJ; Creighton N; Currow DC; Young JM; van Zandwijk N
Aust N Z J Public Health; 2016 Jun; 40(3):255-62. PubMed ID: 26713662
[TBL] [Abstract][Full Text] [Related]
10. Malignant mesothelioma--German mesothelioma register 1987-1999.
Neumann V; Günthe S; Mülle KM; Fischer M
Int Arch Occup Environ Health; 2001 Aug; 74(6):383-95. PubMed ID: 11563601
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Survival among Male and Female Patients with Malignant Pleural Mesothelioma: A Random Survival Forest Analysis of Data from the 2000-2017 Surveillance, Epidemiology, and End Results Program.
Liu B; Niu L; Boscoe F; Lee FF
J Registry Manag; 2021; 48(3):118-125. PubMed ID: 35413729
[TBL] [Abstract][Full Text] [Related]
12. Past trends and future prediction of mesothelioma incidence in an industrialized area of Italy, the Veneto Region.
Girardi P; Bressan V; Merler E
Cancer Epidemiol; 2014 Oct; 38(5):496-503. PubMed ID: 25200195
[TBL] [Abstract][Full Text] [Related]
13. Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.
Meyerhoff RR; Yang CF; Speicher PJ; Gulack BC; Hartwig MG; D'Amico TA; Harpole DH; Berry MF
J Surg Res; 2015 Jun; 196(1):23-32. PubMed ID: 25791825
[TBL] [Abstract][Full Text] [Related]
14. Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States.
Calthorpe L; Romero-Hernandez F; Miller P; Conroy PC; Hirose K; Kim A; Kirkwood K; Nakakura E; Corvera C; Maker AV; Alseidi A; Adam MA
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612225
[TBL] [Abstract][Full Text] [Related]
15. Geographic distribution of incidence of pericardial and paratesticular mesotheliomas in the USA.
Lowry SJ; Weiss NS
Cancer Causes Control; 2016 Dec; 27(12):1487-1489. PubMed ID: 27812913
[TBL] [Abstract][Full Text] [Related]
16. National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study.
Saddoughi SA; Abdelsattar ZM; Blackmon SH
Ann Thorac Surg; 2018 Feb; 105(2):432-437. PubMed ID: 29223422
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes.
Gill RR; Umeoka S; Mamata H; Tilleman TR; Stanwell P; Woodhams R; Padera RF; Sugarbaker DJ; Hatabu H
AJR Am J Roentgenol; 2010 Aug; 195(2):W125-30. PubMed ID: 20651171
[TBL] [Abstract][Full Text] [Related]
18. Longevity and pleural mesothelioma: age-period-cohort analysis of incidence data from the Surveillance, Epidemiology, and End Results (SEER) Program, 1973-2013.
Kerger BD
BMC Res Notes; 2018 May; 11(1):337. PubMed ID: 29792222
[TBL] [Abstract][Full Text] [Related]
19. Ambient Asbestos Fiber Concentrations and Long-Term Trends in Pleural Mesothelioma Incidence between Urban and Rural Areas in the United States (1973-2012).
Glynn ME; Keeton KA; Gaffney SH; Sahmel J
Risk Anal; 2018 Mar; 38(3):454-471. PubMed ID: 28863229
[TBL] [Abstract][Full Text] [Related]
20. Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden.
Hemminki K; Försti A; Chen T; Hemminki A
BMC Cancer; 2021 Nov; 21(1):1189. PubMed ID: 34749677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
